Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk

Aim. To evaluate the antihypertensive efficacy and tolerability of a fixed combination of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods. A retrospective cohort study of real clinical practice of prescribing antihypertensive drugs according...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk
Format: Article
Language:English
Published: Столичная издательская компания 2019-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1796
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227625531179008
author O. Yu. Korennova
S. P. Podolnaya
E. P. Prihodko
E. A. Turusheva
S. N. Starinskaya
I. A. Вratishko
I. V. Druk
author_facet O. Yu. Korennova
S. P. Podolnaya
E. P. Prihodko
E. A. Turusheva
S. N. Starinskaya
I. A. Вratishko
I. V. Druk
author_sort O. Yu. Korennova
collection DOAJ
description Aim. To evaluate the antihypertensive efficacy and tolerability of a fixed combination of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods. A retrospective cohort study of real clinical practice of prescribing antihypertensive drugs according to 255 medical records of outpatient hypertensive patients with a history of acute coronary syndrome (ACS) and coronary artery stenting was performed in the first part. An open observational study was performed in the second part. 69 people older than 18 years with a history of ACS and coronary artery stenting, without reaching the target blood pressure (BP) level while using free combinations of antihypertensive drugs and with indications for a fixed combination of ramipril and amlodipine were included into the study. Analysis of self-monitoring of BP, office BP, daily BP monitoring (ABPM) and patients’ adherence to treatment (Morisky-Green test) initially, after 4 and after 12 weeks of taking the fixed combination of ramipril and amlodipine was performed to assess the clinical efficacy of the studied drug. Results. It was found that 42.0% of patients did not follow the recommendations for regular intake of antihypertensive drugs. So, hypertension of all patients regarded as false-refractory, which was the basis for the prescription of the fixed combination of ramipril and amlodipine in accordance with clinical guidelines for the diagnosis and treatment of hypertension. After 4 weeks of therapy, there was significant decrease in office BP with the achievement and preservation of the target level by the 12th week, normalization to the 12th week of day and night BP variability in 54.9% of patients. 78.0% of patients followed medical recommendations for regular administration of antihypertensive drugs, none of the patients had adverse events. Conclusion. The use of fixed combinations of drugs, in particular, amlodipine and ramipril as a part of multicomponent therapy in hypertensive patients with very high cardiovascular risk, led to the achievement of target BP by the 4th week of therapy and stable preservation of antihypertensive effect in 12 weeks of treatment as well as gradual normalization of day and night BP variability in more than half of patients. Fixed combination of ramipril and amlodipine allowed to improve adherence of patients to cardiovascular diseases.
format Article
id doaj-art-03b563b9f71242c19396ce8fb14f33c0
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2019-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-03b563b9f71242c19396ce8fb14f33c02025-08-23T10:00:30ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-01-0114684084510.20996/1819-6446-2018-14-6-840-8451547Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular RiskO. Yu. Korennova0S. P. Podolnaya1E. P. Prihodko2E. A. Turusheva3S. N. Starinskaya4I. A. Вratishko5I. V. Druk6Omsk State Medical University; Omsk Clinical Cardiology DispensaryOmsk Clinical Cardiology DispensaryOmsk Clinical Cardiology DispensaryOmsk Clinical Cardiology DispensaryOmsk Clinical Cardiology DispensaryOmsk Clinical Cardiology DispensaryOmsk State Medical UniversityAim. To evaluate the antihypertensive efficacy and tolerability of a fixed combination of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods. A retrospective cohort study of real clinical practice of prescribing antihypertensive drugs according to 255 medical records of outpatient hypertensive patients with a history of acute coronary syndrome (ACS) and coronary artery stenting was performed in the first part. An open observational study was performed in the second part. 69 people older than 18 years with a history of ACS and coronary artery stenting, without reaching the target blood pressure (BP) level while using free combinations of antihypertensive drugs and with indications for a fixed combination of ramipril and amlodipine were included into the study. Analysis of self-monitoring of BP, office BP, daily BP monitoring (ABPM) and patients’ adherence to treatment (Morisky-Green test) initially, after 4 and after 12 weeks of taking the fixed combination of ramipril and amlodipine was performed to assess the clinical efficacy of the studied drug. Results. It was found that 42.0% of patients did not follow the recommendations for regular intake of antihypertensive drugs. So, hypertension of all patients regarded as false-refractory, which was the basis for the prescription of the fixed combination of ramipril and amlodipine in accordance with clinical guidelines for the diagnosis and treatment of hypertension. After 4 weeks of therapy, there was significant decrease in office BP with the achievement and preservation of the target level by the 12th week, normalization to the 12th week of day and night BP variability in 54.9% of patients. 78.0% of patients followed medical recommendations for regular administration of antihypertensive drugs, none of the patients had adverse events. Conclusion. The use of fixed combinations of drugs, in particular, amlodipine and ramipril as a part of multicomponent therapy in hypertensive patients with very high cardiovascular risk, led to the achievement of target BP by the 4th week of therapy and stable preservation of antihypertensive effect in 12 weeks of treatment as well as gradual normalization of day and night BP variability in more than half of patients. Fixed combination of ramipril and amlodipine allowed to improve adherence of patients to cardiovascular diseases.https://www.rpcardio.online/jour/article/view/1796arterial hypertensionfixed combinations of antihypertensive drugsefficacytolerabilityadherence
spellingShingle O. Yu. Korennova
S. P. Podolnaya
E. P. Prihodko
E. A. Turusheva
S. N. Starinskaya
I. A. Вratishko
I. V. Druk
Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
Рациональная фармакотерапия в кардиологии
arterial hypertension
fixed combinations of antihypertensive drugs
efficacy
tolerability
adherence
title Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
title_full Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
title_fullStr Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
title_full_unstemmed Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
title_short Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
title_sort antihypertensive efficacy of fixed combination of amlodipine and ramipril in patients with arterial hypertension and very high cardiovascular risk
topic arterial hypertension
fixed combinations of antihypertensive drugs
efficacy
tolerability
adherence
url https://www.rpcardio.online/jour/article/view/1796
work_keys_str_mv AT oyukorennova antihypertensiveefficacyoffixedcombinationofamlodipineandramiprilinpatientswitharterialhypertensionandveryhighcardiovascularrisk
AT sppodolnaya antihypertensiveefficacyoffixedcombinationofamlodipineandramiprilinpatientswitharterialhypertensionandveryhighcardiovascularrisk
AT epprihodko antihypertensiveefficacyoffixedcombinationofamlodipineandramiprilinpatientswitharterialhypertensionandveryhighcardiovascularrisk
AT eaturusheva antihypertensiveefficacyoffixedcombinationofamlodipineandramiprilinpatientswitharterialhypertensionandveryhighcardiovascularrisk
AT snstarinskaya antihypertensiveefficacyoffixedcombinationofamlodipineandramiprilinpatientswitharterialhypertensionandveryhighcardiovascularrisk
AT iavratishko antihypertensiveefficacyoffixedcombinationofamlodipineandramiprilinpatientswitharterialhypertensionandveryhighcardiovascularrisk
AT ivdruk antihypertensiveefficacyoffixedcombinationofamlodipineandramiprilinpatientswitharterialhypertensionandveryhighcardiovascularrisk